HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients.

Abstract
To examine the prognostic value of assessing the concentration of circulating sialyl Tn antigen (STN) after surgery, we determined serum STN levels in peripheral venous blood (designated "p-") in 308 colorectal cancer patients and what we have termed the "d-p gradient" (obtained by subtracting the serum concentration in peripheral venous blood from that in the tumor's drainage venous blood) in 144 patients. The prognostic value of STN and carcinoembryonic antigen (CEA) was compared. Patients were divided into low or high p-antigen groups and low, intermediate, or high d-p gradient groups. Univariate and multivariate analyses revealed that high STN d-p gradient, high p-CEA, or high CEA d-p gradient were each independent variables for poor patient outcome after surgery, separate from stage. In conclusion, a high STN d-p gradient was a predictor of poor outcome after resection for colorectal cancer, while p-STN was not independent of stage.
AuthorsT Nakagoe, T Sawai, T Tsuji, M Jibiki, A Nanashima, H Yamaguchi, N Kurosaki, T Yasutake, H Ayabe, Y Tagawa
JournalAnticancer research (Anticancer Res) 2000 Sep-Oct Vol. 20 Issue 5C Pg. 3863-9 ISSN: 0250-7005 [Print] Greece
PMID11268468 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • sialosyl-Tn antigen
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Antigens, Tumor-Associated, Carbohydrate (blood)
  • Biomarkers, Tumor (blood)
  • Carcinoembryonic Antigen (blood)
  • Colorectal Neoplasms (blood, mortality, pathology, surgery)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: